Clinical Endocannabinoid Deficiency (CED / CECD) or
Clinical Endocannabinoid Deficiency Syndrome (CEDS)
Clinical Endocannabinoid Deficiency (CED / CECD) or Clinical Endocannabinoid Deficiency Syndrome (CEDS) is any condition or illness stemming from a lack of endocannabinoids in the body. In some cases, the body doesn’t naturally produce enough endocannabinoids or enough CB1 and CB2 receptors to sustain homeostasis. When homeostasis stalls, the body becomes unbalanced, and is vulnerable to disease.
Cannabinoid researcher Dr. Ethan Russo first hypothesized his theory of clinical endocannabinoid deficiency in Neuroendocrinology Letters in 2004. His theory proposed that, since the ECS plays a major role in homeostasis, it is possible that CECD may be related to a variety of ailments.
In 2016, Dr. Russo published a follow-up research review, stating that current research supported his initial theory. The research reveals that CECD may cause a hypersensitivity to pain, resulting in (chronic) pain conditions, including irritable bowel syndrome.
Each of these conditions has shown to be resistant to many standard treatments. Someone who has an endocannabinoid deficiency may suffer from one or more of these ailments due to their body’s inability to return to a balanced state.
Human Endocannabinoid System Receptors CB1 and CB2 are located throughout our brain and body. Optimal Health is acquired when these Receptors are communicating, or transmitting information
So How Can endoteas hemp superfoods Help?
endoteas organic hemp superfoods phytonutrients and phytocannabinoid nutrients in microdoses
help maintain our individual and delicate endocannabinid system physiologies.
A few cuppas, or by the iced tea jug, endoessential simple superfoods
provide overall wellness balancing nutrients.